Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sex hormone blood test predicts breast cancer:

This article was originally published in Clinica

Executive Summary

Blood tests for sex hormones in women could help predict their risk of developing breast cancer, a study has shown. Postmenopausal women with high blood levels of oestrogen and testosterone are more than twice as likely to be at risk of the disease as those with low levels of the hormones, a team from Cancer Research UK reported. The study is published in the Journal of the National Cancer Institute (April 17).

Topics

UsernamePublicRestriction

Register

MT066212

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel